Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease.

Russo D, Morrone L, Di Iorio B, Andreucci M, De Gregorio MG, Errichiello C, Russo L, Locatelli F.

J Nephrol. 2015 Dec;28(6):701-8. doi: 10.1007/s40620-014-0129-1. Epub 2014 Aug 12.


Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.

Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.


Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).

Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.

Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.


[Relationship between glomerular filtration rate, uric acid, and parathyroid hormone in children].

Diallo D, Dubourg L, Ranchin B, Cochat P, Bacchetta J.

Arch Pediatr. 2013 Jun;20(6):601-7. doi: 10.1016/j.arcped.2013.03.023. Epub 2013 Apr 30. French.


Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.

Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.

Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.


Impact of BMI on cardiovascular events, renal function, and coronary artery calcification.

Russo D, Morrone LF, Errichiello C, De Gregorio MG, Imbriaco M, Battaglia Y, Russo L, Andreucci M, Di Iorio BR.

Blood Purif. 2014;38(1):1-6. doi: 10.1159/000362862. Epub 2014 Sep 4.


The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW.

Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.


[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].

Lorenzo Sellares V, Torregrosa V.

Nefrologia. 2008;28 Suppl 3:67-78. Spanish.


Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.

Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A.

Clin Nephrol. 2014 Jun;81(6):419-26. doi: 10.5414/CN108166.


The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Memon I, Norris KC, Bomback AS, Peralta C, Li S, Chen SC, McCullough PA, Whaley-Connell A, Jurkovitz C, Tamura MK, Saab G; for the Kidney Early Evaluation Program Investigators.

Cardiorenal Med. 2013 Jul;3(2):120-127. Epub 2013 Jun 1.


Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M.

Kidney Int. 2011 Jun;79(12):1370-8. doi: 10.1038/ki.2011.47. Epub 2011 Mar 9. Erratum in: Kidney Int. 2012 Aug;82(4):498.


Disordered FGF23 and mineral metabolism in children with CKD.

Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB.

Clin J Am Soc Nephrol. 2014 Feb;9(2):344-53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5.


Variation in oral calcitriol response in patients with stages 3-4 CKD.

Shoben AB, Levin G, de Boer IH, Yeung C, Watnick S, Ayers E, Kestenbaum B.

Am J Kidney Dis. 2012 May;59(5):645-52. doi: 10.1053/j.ajkd.2011.11.041. Epub 2012 Jan 29.


Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.

Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P; NephroTest Study Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.


Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.

Genctoy G, Arikan S, Gedik O.

Int Urol Nephrol. 2015 Feb;47(2):353-8. doi: 10.1007/s11255-014-0889-5. Epub 2014 Dec 24.


Relation of serum parathyroid hormone level to severity of heart failure.

Altay H, Zorlu A, Binici S, Bilgi M, Yilmaz MB, Colkesen Y, Erol T, Muderrisoglu H.

Am J Cardiol. 2012 Jan 15;109(2):252-6. doi: 10.1016/j.amjcard.2011.08.039. Epub 2011 Oct 12.


Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.

Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.

Clin Endocrinol (Oxf). 2008 Aug;69(2):189-96. doi: 10.1111/j.1365-2265.2008.03187.x. Epub 2008 Jan 23.


Abnormal Diurnal Patterns of Parathyroid Hormone are Associated with Sustained Mild Hypercalcemia in Non-Dialyzed Chronic Kidney Disease.

Yamato M, Takaori K, Tomiyama Y, Fujimura R, Yokobatake C, Wada A, Ito T.

Clin Lab. 2016;62(1-2):81-8.


Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-to-advanced CKD.

Kovesdy CP, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Sarvary E, Ambrus C, Szathmari M, Remport A, Mucsi I.

Nephron Clin Pract. 2011;118(2):c78-85. doi: 10.1159/000320318. Epub 2010 Dec 8.

Items per page

Supplemental Content

Write to the Help Desk